Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMV-INC-5628125/news/Immunovaccine-Announces-Positive-Interim-Clinical-Data-from-Ovarian-Cancer-Study-of-DPX-Survivac-i-24123244/?utm_source=whatsapp&utm_medium=social&utm_campaign=share